Your browser doesn't support javascript.
loading
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.
Zelenetz, Andrew D; Salles, Gilles; Mason, Kylie D; Casulo, Carla; Le Gouill, Steven; Sehn, Laurie H; Tilly, Herve; Cartron, Guillaume; Chamuleau, Martine E D; Goy, Andre; Tam, Constantine S; Lugtenburg, Pieternella J; Petrich, Adam M; Sinha, Arijit; Samineni, Divya; Herter, Sylvia; Ingalla, Ellen; Szafer-Glusman, Edith; Klein, Christian; Sampath, Deepak; Kornacker, Martin; Mobasher, Mehrdad; Morschhauser, Franck.
Afiliação
  • Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Salles G; Hospices Civils de Lyon, Lyon, France.
  • Mason KD; Faculté de Médecine et de Maïeutique Lyon Sud, Université de Lyon, Lyon, France.
  • Casulo C; Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Le Gouill S; Wilmot Cancer Institute, University of Rochester, Rochester, NY.
  • Sehn LH; Service d'Hématologie, CHU de Nantes, Nantes, France.
  • Tilly H; Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada.
  • Cartron G; Centre Henri Becquerel, Rouen, France.
  • Chamuleau MED; Department of Hematology, University of Montpellier, Montpellier, France.
  • Goy A; HOVON Lunenburg Lymphoma Phase I-II Consortium, VU University Medical Center, Amsterdam, The Netherlands.
  • Tam CS; Hackensack University Medical Center, Hackensack, NJ.
  • Lugtenburg PJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Petrich AM; University of Melbourne, Melbourne, VIC, Australia.
  • Sinha A; HOVON Lunenburg Lymphoma Phase I-II Consortium, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Samineni D; AbbVie, North Chicago, IL.
  • Herter S; Roche Products Ltd, Welwyn Garden City, United Kingdom.
  • Ingalla E; Genentech Inc, South San Francisco, CA.
  • Szafer-Glusman E; Roche Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Klein C; Genentech Inc, South San Francisco, CA.
  • Sampath D; Genentech Inc, South San Francisco, CA.
  • Kornacker M; Roche Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Mobasher M; Genentech Inc, South San Francisco, CA.
  • Morschhauser F; F. Hoffmann-La Roche Ltd, Basel, Switzerland; and.
Blood ; 133(18): 1964-1976, 2019 05 02.
Article em En | MEDLINE | ID: mdl-30850381
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Sulfonamidas / Linfoma não Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Compostos Bicíclicos Heterocíclicos com Pontes Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Sulfonamidas / Linfoma não Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Compostos Bicíclicos Heterocíclicos com Pontes Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article